Of particular importance is that BAFF has been highlighted as a potential target in MS because it is produced endogenously in the CNS by astrocytes during the pathogenesis and it is also associated with BAFF-R expressing cells, which are up-regulated within the meninges in ectopic lymphoid follicles16,60. The gene discussed is TNFSF13B; the disease is myeloid sarcoma.